Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC

Who May Qualify: - Adult participants \> 18 years of age undergoing bilateral cataract surgery - Able to provide written willing to sign a consent form prior to any study related procedure - Able and willing, as assessed by the Investigator, to follow study instructions, complete study assessments, comply with the protocol, and attend study visits for the duration of the study - Patients deemed to be "higher risk" for postoperative complications (e.g., well-controlled diabetes (HbA1c ≤7.0), history of uveitis, history of retinal vein occlusion, history of epiretinal membrane, history of vitreomacular traction, evidence of posterior synechiae, etc.) MAY be enrolled provided there has been no evidence of active disease or treatment in the prior 12 months - Participants who do not meet the exclusion criteria may be enrolled. Who Should NOT Join This Trial: - Cataract surgery combined with any other procedure (e.g., glaucoma, retina, etc.) - Glaucoma patients or known steroid responders - Oral anti-inflammatory medications to treat a systemic disease (exceptions to this include 81 mg aspirin, ibuprofen for headache, etc.) - Intraocular injection within 6 months - Any prior ocular implant - Diagnosis of retinal thickening in the study eye within 12 months of enrollment - Inability to provide willing to sign a consent form - Participation in another clinical trial Always talk to your doctor about whether this trial is right for you.